Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated:  2/11/2016
Intermountain Medical Center
mi
from
Salt Lake City, UT
Premium Migraine Trial
Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects With Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management.
Status: Enrolling
Updated: 2/11/2016
Intermountain Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated:  2/11/2016
University of California at Los Angeles
mi
from
Los Angeles, CA
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated: 2/11/2016
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated:  2/11/2016
Children's Hospital of Orange County
mi
from
Orange, CA
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated: 2/11/2016
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated:  2/11/2016
NYU Langone Medical Center
mi
from
New York, NY
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated: 2/11/2016
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated:  2/11/2016
Duke University
mi
from
Durham, NC
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated: 2/11/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated:  2/11/2016
East Carolina University
mi
from
Greenville, NC
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated: 2/11/2016
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated:  2/11/2016
MetroHealth Med Ctr
mi
from
Cleveland, OH
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated: 2/11/2016
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated:  2/11/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated: 2/11/2016
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated:  2/11/2016
Vanderbilt University
mi
from
Nashville, TN
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated: 2/11/2016
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated:  2/11/2016
Cook Children's Hospital
mi
from
Fort Worth, TX
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated: 2/11/2016
Cook Children's Hospital
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated:  2/11/2016
University of Utah
mi
from
Salt Lake City, UT
Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
A Prospective Randomized Crossover Trial of Oral Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia
Status: Enrolling
Updated: 2/11/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Cedars Sinai Heart Institute
mi
from
Beverly Hills, CA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Cedars Sinai Heart Institute
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Ronald Regan UCLA Medical Center
mi
from
Los Angeles, CA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Ronald Regan UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Stanford University/Palo Alto VA
mi
from
Palo Alto, CA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Stanford University/Palo Alto VA
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Stanford University
mi
from
Stanford, CA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Yale University: New Haven Hospital
mi
from
New Haven, CT
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Yale University: New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
University of Maryland
mi
from
Baltimore, MD
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Massachusetts General Hospital
mi
from
Boston, MA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Tufts Medical Center
mi
from
Boston, MA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Columbia University Medical Center
mi
from
New York, NY
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Drexel University College of Medicine
mi
from
Philadelphia, PA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Allegheny General Hospital
mi
from
Pittsburgh, PA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Medical University of South Carolina
mi
from
Charleston, SC
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Medical City Dallas Hospital/CRSTI
mi
from
Dallas, TX
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Medical City Dallas Hospital/CRSTI
mi
from
Dallas, TX
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Intermountain Medical Center
mi
from
Murray, UT
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Intermountain Medical Center
mi
from
Murray, UT
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
University of Utah
mi
from
Salt Lake City, UT
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Virginia Commonwealth University
mi
from
Richmond, VA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
University of Wisconsin
mi
from
Madison, WI
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
University of California at San Francisco
mi
from
San Francisco, CA
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Northwestern University
mi
from
Chicago, IL
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated:  2/12/2016
Methodist Hospital
mi
from
Houston, TX
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (CTOT-11)
Status: Enrolling
Updated: 2/12/2016
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Coarctation Of the Aorta Stent Trial
Coarctation Of the Aorta Stent Trial
Status: Enrolling
Updated:  2/14/2016
Children's Hospital Boston
mi
from
Boston, MA
Coarctation Of the Aorta Stent Trial
Coarctation Of the Aorta Stent Trial
Status: Enrolling
Updated: 2/14/2016
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Assessment of Acute Disease to Reduce Imaging Costs
Quantitative Pretest Probability to Reduce Cardiopulmonary Imaging in the ED
Status: Enrolling
Updated:  2/15/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Assessment of Acute Disease to Reduce Imaging Costs
Quantitative Pretest Probability to Reduce Cardiopulmonary Imaging in the ED
Status: Enrolling
Updated: 2/15/2016
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Assessment of Acute Disease to Reduce Imaging Costs
Quantitative Pretest Probability to Reduce Cardiopulmonary Imaging in the ED
Status: Enrolling
Updated:  2/15/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Assessment of Acute Disease to Reduce Imaging Costs
Quantitative Pretest Probability to Reduce Cardiopulmonary Imaging in the ED
Status: Enrolling
Updated: 2/15/2016
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Assessment of Acute Disease to Reduce Imaging Costs
Quantitative Pretest Probability to Reduce Cardiopulmonary Imaging in the ED
Status: Enrolling
Updated:  2/15/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Assessment of Acute Disease to Reduce Imaging Costs
Quantitative Pretest Probability to Reduce Cardiopulmonary Imaging in the ED
Status: Enrolling
Updated: 2/15/2016
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Assessment of Acute Disease to Reduce Imaging Costs
Quantitative Pretest Probability to Reduce Cardiopulmonary Imaging in the ED
Status: Enrolling
Updated:  2/15/2016
Forsyth Medical Center
mi
from
Winston-Salem, NC
Assessment of Acute Disease to Reduce Imaging Costs
Quantitative Pretest Probability to Reduce Cardiopulmonary Imaging in the ED
Status: Enrolling
Updated: 2/15/2016
Forsyth Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction
Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  2/15/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction
Acute Effects of Inorganic Nitrite on Cardiovascular Hemodynamics in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 2/15/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
University of AZ College of Medicine
mi
from
Tucson, AZ
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
University of AZ College of Medicine
mi
from
Tucson, AZ
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Center for Clinical Research
mi
from
Castro Valley, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
ILD Consulting, Inc.
mi
from
Encinitas, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
ILD Consulting, Inc.
mi
from
Encinitas, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Vascular Surgery Associates
mi
from
Los Angeles, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Vascular Surgery Associates
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
UCSD Wound Treatment and Research Center
mi
from
San Diego, CA
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
UCSD Wound Treatment and Research Center
mi
from
San Diego, CA
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
University of Miami
mi
from
Miami, FL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated:  2/15/2016
Doctors Research Network
mi
from
South Miami, FL
Dose Finding Study of HP802-247 in Venous Leg Ulcers
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers
Status: Enrolling
Updated: 2/15/2016
Doctors Research Network
mi
from
South Miami, FL
Click here to add this to my saved trials